TranSS, UngarB, BrunnerPM. Treatment of granulomatous perioral dermatitis with 1.5% topical ruxolitinib cream. JAAD Case Rep. 2024; 47:1–3; doi: 10.1016/j.jdcr.2024.02.022
2.
SrourJ, BengelJ, LindenT, et al.Efficacy of a skin care cream with TRPV1 inhibitor 4-t-butylcyclohexanol in the topical therapy of perioral dermatitis. J Cosmet Dermatol. 2020; 19(6):1409–1414; doi: 10.1111/jocd.13175
3.
KanohS, RubinBK. Mechanisms of action and clinical application of macrolides as immunomodulatory medications. Clin Microbiol Rev. 2010; 23(3):590–615; doi: 10.1128/cmr.00078-09
4.
GutfreundK, BieniasW, SzewczykA, et al.Topical calcineurin inhibitors in dermatology. Part I: Properties, method and effectiveness of drug use. Postepy Dermatol Alergol. 2013; 30(3):165–169; doi: 10.5114/pdia.2013.35619
5.
EyohE, McCallumP, KillickJ, et al.The anthelmintic drug praziquantel promotes human Tr1 differentiation. Immunol Cell Biol. 2019; 97(5):512–518; doi: 10.1111/imcb.12229
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
